Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.
about
Neonatal pain management: still in search for the Holy GrailAssociation of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury.A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis.PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophenAcetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease.Pharmacogenomics of acetaminophen in pediatric populations: a moving target.Acetaminophen hepatotoxicity: an updated review.Transcriptome association analysis identifies miR-375 as a major determinant of variable acetaminophen glucuronidation by human liver.The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development.Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury?Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature.Editor's Highlight: Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach.Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective
P2860
Q28078751-C99E01EF-0DCC-4D13-A56F-761D693C5256Q33600448-FCD5C632-6CC1-465A-8027-33A1F769C8D8Q34208933-D49C7FF6-A819-4DBA-AC6F-3598F00DA9BBQ35842112-C2B12E6A-6C05-426D-92BD-024DEB46D9A0Q36669589-45808439-A735-45DA-A1BF-6F8CE71E49B9Q38191681-4CAF08E0-7E88-48DA-A7F8-F133CB317DCFQ38263519-6BF5E744-209B-4668-8132-49F4CBC73302Q38299336-DA3399AB-356B-4D35-A077-62AD6BB0195EQ38751501-FC642B52-41DB-4028-9222-79DB65A25586Q38774776-FB645711-8E8E-4489-9C27-24CAC3C7BDD1Q39061191-92AEFEDA-F115-4EF4-9C46-8591258BEA60Q46140298-ED1C2A6F-1EB5-44F9-AEF2-93D4D81A5678Q49214888-CE7B2380-FD8C-47BC-891F-22F49F1ACCC8Q51172729-BB0F98D9-104F-4F23-81E4-B169E8A5FDA2Q58045340-F13CD68C-B853-4A5D-A8A9-B6DAE6E47F1D
P2860
Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.
@en
Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.
@nl
type
label
Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.
@en
Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.
@nl
prefLabel
Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.
@en
Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.
@nl
P2093
P2860
P356
P1476
Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.
@en
P2093
Acute Liver Failure Study Group
David J Greenblatt
Inga Peter
Magdalini Vasiadi
Michael H Court
Suwagmani Hazarika
William M Lee
P2860
P356
10.1124/DMD.113.053546
P577
2013-10-08T00:00:00Z